Baseline Epigenetics as a Biomarker of Mepolizumab Response in Severe Asthma

Clin Exp Allergy. 2025 Dec 12. doi: 10.1111/cea.70195. Online ahead of print.

Authors

Hongmei Zhang¹, Xin Jin¹, Hasan Arshad^{2

3}, Ramesh J Kurukulaaratchy^{2

3}

Affiliations

¹ Division of Epidemiology, Biostatistics, Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee, USA.
² The David Hide Asthma and Allergy Research Centre, St. Mary's Hospital, Isle of Wight, UK.
³ Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

PMID: 41387235
DOI: 10.1111/cea.70195

No abstract available

Keywords: DNA methylation; biologic drugs; markers; prediction; severe asthma.

Grants and funding

R21AI175891/NH/NIH HHS/United States